Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Structural and functional vascular dysfunction within brain metastases is linked to pembrolizumab inefficacy.
Journal: bioRxiv : the preprint server for biology
Published: September 11, 2023
Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells.
Journal: Neuro-oncology
Published: July 04, 2023
Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results.
Journal: Nature medicine
Published: March 08, 2023
Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas.
Journal: Nature communications
Published: August 18, 2021
Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis.
Journal: Nature communications
Published: November 14, 2020
Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 11, 2018
Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival.
Journal: NPJ precision oncology
Published: December 05, 2017
Impact of histopathological transformation and overall survival in patients with progressive anaplastic glioma.
Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Published: February 02, 2016
Vandetanib plus sirolimus in adults with recurrent glioblastoma: results of a phase I and dose expansion cohort study.
Journal: Journal of neuro-oncology
Published: September 29, 2014
Last Updated: 09/26/2026